Prevalence and Trends of Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus 1, 2 and Syphilis Infections Among Blood Donors in a Regional Transfusion Center in Punjab, India: A 3 Years Study
Overview
Authors
Affiliations
Background: Accurate estimates of the risk of transfusion-transmitted infectious diseases are essential for monitoring the safety of blood supply and evaluating the potential effects of new screening tests.
Objective: The aim was to determine changes over time in blood donor population infection rates of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV-1, 2) and syphilis.
Materials And Methods: Changes in rates of HBV, HCV, HIV-1, 2, and syphilis infections were evaluated by comparing yearly prevalence rates for blood donors over 3 years, that is, between January 1, 2012 and December 31, 2014. Serological tests were done according to the standard operating procedures and manufacturer's instructions and included the following: tests for hepatitis B surface antigen; antibodies to HCV and HIV-1, 2 and rapid plasma reagin test for syphilis.
Results: Nearly 2.54 of the total screened blood donors were reactive for one of the four transfusion transmitted infections (TTIs) with higher prevalence in replacement (3%) than voluntary donors (2.3%) and in male (2.54%) than female (2.3%) donors. TTI tend to be more (54.7%) in younger population of 18-30 years. HCV infection is the most common of all TTI (50%).
Conclusion: The rising prevalence rates of HIV; HBV; HCV and syphilis among different groups suggests that blood transfusion is still very unsafe in this community and emphasis should be laid on donor education and donor self-exclusion, implementation of strict donor screening criteria, pre-donation counseling, and more sensitive screening methods. Furthermore, donors with a history of sexually transmitted infections should be totally excluded from all donations.
Shrivastava M, Agrawal A, Das S, Mishra S Indian J Med Res. 2024; 160(2):155-164.
PMID: 39513206 PMC: 11544571. DOI: 10.25259/ijmr_285_24.
Kumari S, Kumar A, Kapoor S, Saroj U, Verma S, Kumar D Cureus. 2024; 16(8):e66404.
PMID: 39247033 PMC: 11379535. DOI: 10.7759/cureus.66404.
Mangala C, Maulot-Bangola D, Moutsinga A, Okolongo-Mayani S, Matsomo-Kombet G, Moundanga M PLoS One. 2024; 19(8):e0307101.
PMID: 39159193 PMC: 11332953. DOI: 10.1371/journal.pone.0307101.
Bansal N, Gupta A, Sidhu T, Maharishi R, Gupta S, Roychoudhury A J Family Med Prim Care. 2023; 12(10):2359-2365.
PMID: 38074241 PMC: 10706503. DOI: 10.4103/jfmpc.jfmpc_490_23.
Chen X, Liu Q, Sun P, Yuan S, Liao H, Zhang X Infect Drug Resist. 2022; 15:6431-6440.
PMID: 36349217 PMC: 9637336. DOI: 10.2147/IDR.S386495.